Global Recombinant Hepatitis B Vaccine Market Research Report 2022

Publisher Name :
Date: 03-Aug-2022
No. of pages: 91
Inquire Before Buying

The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type

- 10mcg/ml

- 10mcg/0.5ml

Segment by Application

- Newborn

- Primary School Students

- Adult

By Region

- North America

- - U.S.

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - India

- - Australia

- - Taiwan

- - Indonesia

- - Thailand

- - Malaysia

- - Philippines

- - Vietnam

- Latin America

- - Mexico

- - Brazil

- - Argentina

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

By Company

- Merck

- GlaxoSmithKline Plc

- Pfizer Inc.

- Sanofi Pasteur

- CSL Limited

- Emergent Biosolutions

- Serum Institute of India

- Johnson & Johnson

- Hualan Biological Engineering

- NCPC

- China National Biotec Group

- Dalian Hissen Bio-pharm

- Beijing Tiantan Biological

Global Recombinant Hepatitis B Vaccine Market Research Report 2022

Table of Contents
1 Recombinant Hepatitis B Vaccine Market Overview
1.1 Product Overview and Scope of Recombinant Hepatitis B Vaccine
1.2 Recombinant Hepatitis B Vaccine Segment by Type
1.2.1 Global Recombinant Hepatitis B Vaccine Sales Growth Rate Comparison by Type (2022-2028)
1.2.2 10mcg/ml
1.2.3 10mcg/0.5ml
1.3 Recombinant Hepatitis B Vaccine Segment by Application
1.3.1 Global Recombinant Hepatitis B Vaccine Sales Comparison by Application: (2022-2028)
1.3.2 Newborn
1.3.3 Primary School Students
1.3.4 Adult
1.4 Global Recombinant Hepatitis B Vaccine Market Size Estimates and Forecasts
1.4.1 Global Recombinant Hepatitis B Vaccine Revenue 2017-2028
1.4.2 Global Recombinant Hepatitis B Vaccine Sales 2017-2028
1.4.3 Recombinant Hepatitis B Vaccine Market Size by Region: 2017 Versus 2021 Versus 2028
2 Recombinant Hepatitis B Vaccine Market Competition by Manufacturers
2.1 Global Recombinant Hepatitis B Vaccine Sales Market Share by Manufacturers (2017-2022)
2.2 Global Recombinant Hepatitis B Vaccine Revenue Market Share by Manufacturers (2017-2022)
2.3 Global Recombinant Hepatitis B Vaccine Average Price by Manufacturers (2017-2022)
2.4 Manufacturers Recombinant Hepatitis B Vaccine Manufacturing Sites, Area Served, Product Type
2.5 Recombinant Hepatitis B Vaccine Market Competitive Situation and Trends
2.5.1 Recombinant Hepatitis B Vaccine Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Recombinant Hepatitis B Vaccine Players Market Share by Revenue
2.5.3 Global Recombinant Hepatitis B Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Recombinant Hepatitis B Vaccine Retrospective Market Scenario by Region
3.1 Global Recombinant Hepatitis B Vaccine Retrospective Market Scenario in Sales by Region: 2017-2022
3.2 Global Recombinant Hepatitis B Vaccine Retrospective Market Scenario in Revenue by Region: 2017-2022
3.3 North America Recombinant Hepatitis B Vaccine Market Facts & Figures by Country
3.3.1 North America Recombinant Hepatitis B Vaccine Sales by Country
3.3.2 North America Recombinant Hepatitis B Vaccine Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Recombinant Hepatitis B Vaccine Market Facts & Figures by Country
3.4.1 Europe Recombinant Hepatitis B Vaccine Sales by Country
3.4.2 Europe Recombinant Hepatitis B Vaccine Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Recombinant Hepatitis B Vaccine Market Facts & Figures by Region
3.5.1 Asia Pacific Recombinant Hepatitis B Vaccine Sales by Region
3.5.2 Asia Pacific Recombinant Hepatitis B Vaccine Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Recombinant Hepatitis B Vaccine Market Facts & Figures by Country
3.6.1 Latin America Recombinant Hepatitis B Vaccine Sales by Country
3.6.2 Latin America Recombinant Hepatitis B Vaccine Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Recombinant Hepatitis B Vaccine Market Facts & Figures by Country
3.7.1 Middle East and Africa Recombinant Hepatitis B Vaccine Sales by Country
3.7.2 Middle East and Africa Recombinant Hepatitis B Vaccine Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Recombinant Hepatitis B Vaccine Historic Market Analysis by Type
4.1 Global Recombinant Hepatitis B Vaccine Sales Market Share by Type (2017-2022)
4.2 Global Recombinant Hepatitis B Vaccine Revenue Market Share by Type (2017-2022)
4.3 Global Recombinant Hepatitis B Vaccine Price by Type (2017-2022)
5 Global Recombinant Hepatitis B Vaccine Historic Market Analysis by Application
5.1 Global Recombinant Hepatitis B Vaccine Sales Market Share by Application (2017-2022)
5.2 Global Recombinant Hepatitis B Vaccine Revenue Market Share by Application (2017-2022)
5.3 Global Recombinant Hepatitis B Vaccine Price by Application (2017-2022)
6 Key Companies Profiled
6.1 Merck
6.1.1 Merck Corporation Information
6.1.2 Merck Description and Business Overview
6.1.3 Merck Recombinant Hepatitis B Vaccine Sales, Revenue and Gross Margin (2017-2022)
6.1.4 Merck Recombinant Hepatitis B Vaccine Product Portfolio
6.1.5 Merck Recent Developments/Updates
6.2 GlaxoSmithKline Plc
6.2.1 GlaxoSmithKline Plc Corporation Information
6.2.2 GlaxoSmithKline Plc Description and Business Overview
6.2.3 GlaxoSmithKline Plc Recombinant Hepatitis B Vaccine Sales, Revenue and Gross Margin (2017-2022)
6.2.4 GlaxoSmithKline Plc Recombinant Hepatitis B Vaccine Product Portfolio
6.2.5 GlaxoSmithKline Plc Recent Developments/Updates
6.3 Pfizer Inc.
6.3.1 Pfizer Inc. Corporation Information
6.3.2 Pfizer Inc. Description and Business Overview
6.3.3 Pfizer Inc. Recombinant Hepatitis B Vaccine Sales, Revenue and Gross Margin (2017-2022)
6.3.4 Pfizer Inc. Recombinant Hepatitis B Vaccine Product Portfolio
6.3.5 Pfizer Inc. Recent Developments/Updates
6.4 Sanofi Pasteur
6.4.1 Sanofi Pasteur Corporation Information
6.4.2 Sanofi Pasteur Description and Business Overview
6.4.3 Sanofi Pasteur Recombinant Hepatitis B Vaccine Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Sanofi Pasteur Recombinant Hepatitis B Vaccine Product Portfolio
6.4.5 Sanofi Pasteur Recent Developments/Updates
6.5 CSL Limited
6.5.1 CSL Limited Corporation Information
6.5.2 CSL Limited Description and Business Overview
6.5.3 CSL Limited Recombinant Hepatitis B Vaccine Sales, Revenue and Gross Margin (2017-2022)
6.5.4 CSL Limited Recombinant Hepatitis B Vaccine Product Portfolio
6.5.5 CSL Limited Recent Developments/Updates
6.6 Emergent Biosolutions
6.6.1 Emergent Biosolutions Corporation Information
6.6.2 Emergent Biosolutions Description and Business Overview
6.6.3 Emergent Biosolutions Recombinant Hepatitis B Vaccine Sales, Revenue and Gross Margin (2017-2022)
6.6.4 Emergent Biosolutions Recombinant Hepatitis B Vaccine Product Portfolio
6.6.5 Emergent Biosolutions Recent Developments/Updates
6.7 Serum Institute of India
6.6.1 Serum Institute of India Corporation Information
6.6.2 Serum Institute of India Description and Business Overview
6.6.3 Serum Institute of India Recombinant Hepatitis B Vaccine Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Serum Institute of India Recombinant Hepatitis B Vaccine Product Portfolio
6.7.5 Serum Institute of India Recent Developments/Updates
6.8 Johnson & Johnson
6.8.1 Johnson & Johnson Corporation Information
6.8.2 Johnson & Johnson Description and Business Overview
6.8.3 Johnson & Johnson Recombinant Hepatitis B Vaccine Sales, Revenue and Gross Margin (2017-2022)
6.8.4 Johnson & Johnson Recombinant Hepatitis B Vaccine Product Portfolio
6.8.5 Johnson & Johnson Recent Developments/Updates
6.9 Hualan Biological Engineering
6.9.1 Hualan Biological Engineering Corporation Information
6.9.2 Hualan Biological Engineering Description and Business Overview
6.9.3 Hualan Biological Engineering Recombinant Hepatitis B Vaccine Sales, Revenue and Gross Margin (2017-2022)
6.9.4 Hualan Biological Engineering Recombinant Hepatitis B Vaccine Product Portfolio
6.9.5 Hualan Biological Engineering Recent Developments/Updates
6.10 NCPC
6.10.1 NCPC Corporation Information
6.10.2 NCPC Description and Business Overview
6.10.3 NCPC Recombinant Hepatitis B Vaccine Sales, Revenue and Gross Margin (2017-2022)
6.10.4 NCPC Recombinant Hepatitis B Vaccine Product Portfolio
6.10.5 NCPC Recent Developments/Updates
6.11 China National Biotec Group
6.11.1 China National Biotec Group Corporation Information
6.11.2 China National Biotec Group Recombinant Hepatitis B Vaccine Description and Business Overview
6.11.3 China National Biotec Group Recombinant Hepatitis B Vaccine Sales, Revenue and Gross Margin (2017-2022)
6.11.4 China National Biotec Group Recombinant Hepatitis B Vaccine Product Portfolio
6.11.5 China National Biotec Group Recent Developments/Updates
6.12 Dalian Hissen Bio-pharm
6.12.1 Dalian Hissen Bio-pharm Corporation Information
6.12.2 Dalian Hissen Bio-pharm Recombinant Hepatitis B Vaccine Description and Business Overview
6.12.3 Dalian Hissen Bio-pharm Recombinant Hepatitis B Vaccine Sales, Revenue and Gross Margin (2017-2022)
6.12.4 Dalian Hissen Bio-pharm Recombinant Hepatitis B Vaccine Product Portfolio
6.12.5 Dalian Hissen Bio-pharm Recent Developments/Updates
6.13 Beijing Tiantan Biological
6.13.1 Beijing Tiantan Biological Corporation Information
6.13.2 Beijing Tiantan Biological Recombinant Hepatitis B Vaccine Description and Business Overview
6.13.3 Beijing Tiantan Biological Recombinant Hepatitis B Vaccine Sales, Revenue and Gross Margin (2017-2022)
6.13.4 Beijing Tiantan Biological Recombinant Hepatitis B Vaccine Product Portfolio
6.13.5 Beijing Tiantan Biological Recent Developments/Updates
7 Recombinant Hepatitis B Vaccine Manufacturing Cost Analysis
7.1 Recombinant Hepatitis B Vaccine Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Recombinant Hepatitis B Vaccine
7.4 Recombinant Hepatitis B Vaccine Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Recombinant Hepatitis B Vaccine Distributors List
8.3 Recombinant Hepatitis B Vaccine Customers
9 Recombinant Hepatitis B Vaccine Market Dynamics
9.1 Recombinant Hepatitis B Vaccine Industry Trends
9.2 Recombinant Hepatitis B Vaccine Market Drivers
9.3 Recombinant Hepatitis B Vaccine Market Challenges
9.4 Recombinant Hepatitis B Vaccine Market Restraints
10 Global Market Forecast
10.1 Recombinant Hepatitis B Vaccine Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Recombinant Hepatitis B Vaccine by Type (2023-2028)
10.1.2 Global Forecasted Revenue of Recombinant Hepatitis B Vaccine by Type (2023-2028)
10.2 Recombinant Hepatitis B Vaccine Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Recombinant Hepatitis B Vaccine by Application (2023-2028)
10.2.2 Global Forecasted Revenue of Recombinant Hepatitis B Vaccine by Application (2023-2028)
10.3 Recombinant Hepatitis B Vaccine Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Recombinant Hepatitis B Vaccine by Region (2023-2028)
10.3.2 Global Forecasted Revenue of Recombinant Hepatitis B Vaccine by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Recombinant Hepatitis B Vaccine Sales Growth Rate Comparison by Type (2022-2028) & (K Units) & (US$ Million)
Table 2. Global Recombinant Hepatitis B Vaccine Sales Growth Rate Comparison by Application (2022-2028) & (K Units) & (US$ Million)
Table 3. Global Recombinant Hepatitis B Vaccine Market Size by Region (US$ Million) (2017 VS 2021 VS 2028)
Table 4. Global Recombinant Hepatitis B Vaccine Market Competitive Situation by Manufacturers in 2021
Table 5. Global Recombinant Hepatitis B Vaccine Sales (K Units) of Key Manufacturers (2017-2022)
Table 6. Global Recombinant Hepatitis B Vaccine Sales Market Share by Manufacturers (2017-2022)
Table 7. Global Recombinant Hepatitis B Vaccine Revenue (US$ Million) by Manufacturers (2017-2022)
Table 8. Global Recombinant Hepatitis B Vaccine Revenue Share by Manufacturers (2017-2022)
Table 9. Global Market Recombinant Hepatitis B Vaccine Average Price (US$/Unit) of Key Manufacturers (2017-2022)
Table 10. Manufacturers Recombinant Hepatitis B Vaccine Manufacturing Sites and Area Served
Table 11. Manufacturers Recombinant Hepatitis B Vaccine Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Recombinant Hepatitis B Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Recombinant Hepatitis B Vaccine as of 2021)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Recombinant Hepatitis B Vaccine Sales by Region (2017-2022) & (K Units)
Table 16. Global Recombinant Hepatitis B Vaccine Sales Market Share by Region (2017-2022)
Table 17. Global Recombinant Hepatitis B Vaccine Revenue by Region (2017-2022) & (US$ Million)
Table 18. Global Recombinant Hepatitis B Vaccine Revenue Market Share by Region (2017-2022)
Table 19. North America Recombinant Hepatitis B Vaccine Sales by Country (2017-2022) & (K Units)
Table 20. North America Recombinant Hepatitis B Vaccine Sales Market Share by Country (2017-2022)
Table 21. North America Recombinant Hepatitis B Vaccine Revenue by Country (2017-2022) & (US$ Million)
Table 22. North America Recombinant Hepatitis B Vaccine Revenue Market Share by Country (2017-2022)
Table 23. Europe Recombinant Hepatitis B Vaccine Sales by Country (2017-2022) & (K Units)
Table 24. Europe Recombinant Hepatitis B Vaccine Sales Market Share by Country (2017-2022)
Table 25. Europe Recombinant Hepatitis B Vaccine Revenue by Country (2017-2022) & (US$ Million)
Table 26. Europe Recombinant Hepatitis B Vaccine Revenue Market Share by Country (2017-2022)
Table 27. Asia Pacific Recombinant Hepatitis B Vaccine Sales by Region (2017-2022) & (K Units)
Table 28. Asia Pacific Recombinant Hepatitis B Vaccine Sales Market Share by Region (2017-2022)
Table 29. Asia Pacific Recombinant Hepatitis B Vaccine Revenue by Region (2017-2022) & (US$ Million)
Table 30. Asia Pacific Recombinant Hepatitis B Vaccine Revenue Market Share by Region (2017-2022)
Table 31. Latin America Recombinant Hepatitis B Vaccine Sales by Country (2017-2022) & (K Units)
Table 32. Latin America Recombinant Hepatitis B Vaccine Sales Market Share by Country (2017-2022)
Table 33. Latin America Recombinant Hepatitis B Vaccine Revenue by Country (2017-2022) & (US$ Million)
Table 34. Latin America Recombinant Hepatitis B Vaccine Revenue Market Share by Country (2017-2022)
Table 35. Middle East and Africa Recombinant Hepatitis B Vaccine Sales by Country (2017-2022) & (K Units)
Table 36. Middle East and Africa Recombinant Hepatitis B Vaccine Sales Market Share by Country (2017-2022)
Table 37. Middle East and Africa Recombinant Hepatitis B Vaccine Revenue by Country (2017-2022) & (US$ Million)
Table 38. Middle East and Africa Recombinant Hepatitis B Vaccine Revenue Market Share by Country (2017-2022)
Table 39. Global Recombinant Hepatitis B Vaccine Sales by Type (2017-2022) & (K Units)
Table 40. Global Recombinant Hepatitis B Vaccine Sales Market Share by Type (2017-2022)
Table 41. Global Recombinant Hepatitis B Vaccine Revenue by Type (2017-2022) & (US$ Million)
Table 42. Global Recombinant Hepatitis B Vaccine Revenue Share by Type (2017-2022)
Table 43. Global Recombinant Hepatitis B Vaccine Price by Type (2017-2022) & (US$/Unit)
Table 44. Global Recombinant Hepatitis B Vaccine Sales (K Units) by Application (2017-2022)
Table 45. Global Recombinant Hepatitis B Vaccine Sales Market Share by Application (2017-2022)
Table 46. Global Recombinant Hepatitis B Vaccine Revenue by Application (2017-2022) & (US$ Million)
Table 47. Global Recombinant Hepatitis B Vaccine Revenue Share by Application (2017-2022)
Table 48. Global Recombinant Hepatitis B Vaccine Price by Application (2017-2022) & (US$/Unit)
Table 49. Merck Corporation Information
Table 50. Merck Description and Business Overview
Table 51. Merck Recombinant Hepatitis B Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 52. Merck Recombinant Hepatitis B Vaccine Product
Table 53. Merck Recent Developments/Updates
Table 54. GlaxoSmithKline Plc Corporation Information
Table 55. GlaxoSmithKline Plc Description and Business Overview
Table 56. GlaxoSmithKline Plc Recombinant Hepatitis B Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 57. GlaxoSmithKline Plc Recombinant Hepatitis B Vaccine Product
Table 58. GlaxoSmithKline Plc Recent Developments/Updates
Table 59. Pfizer Inc. Corporation Information
Table 60. Pfizer Inc. Description and Business Overview
Table 61. Pfizer Inc. Recombinant Hepatitis B Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 62. Pfizer Inc. Recombinant Hepatitis B Vaccine Product
Table 63. Pfizer Inc. Recent Developments/Updates
Table 64. Sanofi Pasteur Corporation Information
Table 65. Sanofi Pasteur Description and Business Overview
Table 66. Sanofi Pasteur Recombinant Hepatitis B Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 67. Sanofi Pasteur Recombinant Hepatitis B Vaccine Product
Table 68. Sanofi Pasteur Recent Developments/Updates
Table 69. CSL Limited Corporation Information
Table 70. CSL Limited Description and Business Overview
Table 71. CSL Limited Recombinant Hepatitis B Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 72. CSL Limited Recombinant Hepatitis B Vaccine Product
Table 73. CSL Limited Recent Developments/Updates
Table 74. Emergent Biosolutions Corporation Information
Table 75. Emergent Biosolutions Description and Business Overview
Table 76. Emergent Biosolutions Recombinant Hepatitis B Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 77. Emergent Biosolutions Recombinant Hepatitis B Vaccine Product
Table 78. Emergent Biosolutions Recent Developments/Updates
Table 79. Serum Institute of India Corporation Information
Table 80. Serum Institute of India Description and Business Overview
Table 81. Serum Institute of India Recombinant Hepatitis B Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 82. Serum Institute of India Recombinant Hepatitis B Vaccine Product
Table 83. Serum Institute of India Recent Developments/Updates
Table 84. Johnson & Johnson Corporation Information
Table 85. Johnson & Johnson Description and Business Overview
Table 86. Johnson & Johnson Recombinant Hepatitis B Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 87. Johnson & Johnson Recombinant Hepatitis B Vaccine Product
Table 88. Johnson & Johnson Recent Developments/Updates
Table 89. Hualan Biological Engineering Corporation Information
Table 90. Hualan Biological Engineering Description and Business Overview
Table 91. Hualan Biological Engineering Recombinant Hepatitis B Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 92. Hualan Biological Engineering Recombinant Hepatitis B Vaccine Product
Table 93. Hualan Biological Engineering Recent Developments/Updates
Table 94. NCPC Corporation Information
Table 95. NCPC Description and Business Overview
Table 96. NCPC Recombinant Hepatitis B Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 97. NCPC Recombinant Hepatitis B Vaccine Product
Table 98. NCPC Recent Developments/Updates
Table 99. China National Biotec Group Corporation Information
Table 100. China National Biotec Group Description and Business Overview
Table 101. China National Biotec Group Recombinant Hepatitis B Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 102. China National Biotec Group Recombinant Hepatitis B Vaccine Product
Table 103. China National Biotec Group Recent Developments/Updates
Table 104. Dalian Hissen Bio-pharm Corporation Information
Table 105. Dalian Hissen Bio-pharm Description and Business Overview
Table 106. Dalian Hissen Bio-pharm Recombinant Hepatitis B Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 107. Dalian Hissen Bio-pharm Recombinant Hepatitis B Vaccine Product
Table 108. Dalian Hissen Bio-pharm Recent Developments/Updates
Table 109. Beijing Tiantan Biological Corporation Information
Table 110. Beijing Tiantan Biological Description and Business Overview
Table 111. Beijing Tiantan Biological Recombinant Hepatitis B Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 112. Beijing Tiantan Biological Recombinant Hepatitis B Vaccine Product
Table 113. Beijing Tiantan Biological Recent Developments/Updates
Table 114. Production Base and Market Concentration Rate of Raw Material
Table 115. Key Suppliers of Raw Materials
Table 116. Recombinant Hepatitis B Vaccine Distributors List
Table 117. Recombinant Hepatitis B Vaccine Customers List
Table 118. Recombinant Hepatitis B Vaccine Market Trends
Table 119. Recombinant Hepatitis B Vaccine Market Drivers
Table 120. Recombinant Hepatitis B Vaccine Market Challenges
Table 121. Recombinant Hepatitis B Vaccine Market Restraints
Table 122. Global Recombinant Hepatitis B Vaccine Sales Forecast by Type (2023-2028) & (K Units)
Table 123. Global Recombinant Hepatitis B Vaccine Sales Market Share Forecast by Type (2023-2028)
Table 124. Global Recombinant Hepatitis B Vaccine Revenue Forecast by Type (2023-2028) & (US$ Million)
Table 125. Global Recombinant Hepatitis B Vaccine Revenue Market Share Forecast by Type (2023-2028)
Table 126. Global Recombinant Hepatitis B Vaccine Sales Forecast by Application (2023-2028) & (K Units)
Table 127. Global Recombinant Hepatitis B Vaccine Sales Market Share Forecast by Application (2023-2028)
Table 128. Global Recombinant Hepatitis B Vaccine Revenue Forecast by Application (2023-2028) & (US$ Million)
Table 129. Global Recombinant Hepatitis B Vaccine Revenue Market Share Forecast by Application (2023-2028)
Table 130. Global Recombinant Hepatitis B Vaccine Sales Forecast by Region (2023-2028) & (K Units)
Table 131. Global Recombinant Hepatitis B Vaccine Sales Market Share Forecast by Region (2023-2028)
Table 132. Global Recombinant Hepatitis B Vaccine Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 133. Global Recombinant Hepatitis B Vaccine Revenue Market Share Forecast by Region (2023-2028)
Table 134. Research Programs/Design for This Report
Table 135. Key Data Information from Secondary Sources
Table 136. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Recombinant Hepatitis B Vaccine
Figure 2. Global Recombinant Hepatitis B Vaccine Market Share by Type in 2021 & 2028
Figure 3. 10mcg/ml Product Picture
Figure 4. 10mcg/0.5ml Product Picture
Figure 5. Global Recombinant Hepatitis B Vaccine Market Share by Application in 2021 & 2028
Figure 6. Newborn
Figure 7. Primary School Students
Figure 8. Adult
Figure 9. Global Recombinant Hepatitis B Vaccine Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 10. Global Recombinant Hepatitis B Vaccine Market Size (2017-2028) & (US$ Million)
Figure 11. Global Recombinant Hepatitis B Vaccine Sales (2017-2028) & (K Units)
Figure 12. Recombinant Hepatitis B Vaccine Sales Share by Manufacturers in 2021
Figure 13. Global Recombinant Hepatitis B Vaccine Revenue Share by Manufacturers in 2021
Figure 14. The Global 5 and 10 Largest Recombinant Hepatitis B Vaccine Players: Market Share by Revenue in 2021
Figure 15. Recombinant Hepatitis B Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 16. Global Recombinant Hepatitis B Vaccine Sales Market Share by Region (2017-2022)
Figure 17. Global Recombinant Hepatitis B Vaccine Sales Market Share by Region in 2021
Figure 18. Global Recombinant Hepatitis B Vaccine Revenue Market Share by Region (2017-2022)
Figure 19. Global Recombinant Hepatitis B Vaccine Revenue Market Share by Region in 2021
Figure 20. U.S. Recombinant Hepatitis B Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 21. Canada Recombinant Hepatitis B Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 22. Germany Recombinant Hepatitis B Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 23. France Recombinant Hepatitis B Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 24. U.K. Recombinant Hepatitis B Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 25. Italy Recombinant Hepatitis B Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 26. Russia Recombinant Hepatitis B Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 27. China Recombinant Hepatitis B Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 28. Japan Recombinant Hepatitis B Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 29. South Korea Recombinant Hepatitis B Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 30. India Recombinant Hepatitis B Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 31. Australia Recombinant Hepatitis B Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 32. Taiwan Recombinant Hepatitis B Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 33. Indonesia Recombinant Hepatitis B Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 34. Thailand Recombinant Hepatitis B Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 35. Malaysia Recombinant Hepatitis B Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 36. Philippines Recombinant Hepatitis B Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 37. Vietnam Recombinant Hepatitis B Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 38. Mexico Recombinant Hepatitis B Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 39. Brazil Recombinant Hepatitis B Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 40. Argentina Recombinant Hepatitis B Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 41. Turkey Recombinant Hepatitis B Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 42. Saudi Arabia Recombinant Hepatitis B Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 43. UAE Recombinant Hepatitis B Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 44. Sales Market Share of Recombinant Hepatitis B Vaccine by Type (2017-2022)
Figure 45. Manufacturing Cost Structure of Recombinant Hepatitis B Vaccine
Figure 46. Manufacturing Process Analysis of Recombinant Hepatitis B Vaccine
Figure 47. Recombinant Hepatitis B Vaccine Industrial Chain Analysis
Figure 48. Channels of Distribution
Figure 49. Distributors Profiles
Figure 50. Bottom-up and Top-down Approaches for This Report
Figure 51. Data Triangulation
Figure 52. Key Executives Interviewed
  • Global Scar Treatment Oils Market Research Report 2022
    Published: 12-Aug-2022        Price: US 2900 Onwards        Pages: 93
    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type - Natural - Synthetic Segment by Application - Hospitals - Dermatology Clinics ......
  • Global Injection Anesthetic Drugs Market Research Report 2022
    Published: 12-Aug-2022        Price: US 2900 Onwards        Pages: 98
    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type - General Anesthesia Drugs - Local Anesthesia Drugs Segment by Application - Cosmetic Surgery......
  • Global Opioid Pain Patche Market Research Report 2022
    Published: 12-Aug-2022        Price: US 2900 Onwards        Pages: 93
    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type - Opioid Patches - Non-opioid Patches Segment by Application - Hospital Pharmacies - Re......
  • Global Pain Patches Market Research Report 2022
    Published: 12-Aug-2022        Price: US 2900 Onwards        Pages: 98
    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type - Buprenorphine - Fentanyl Segment by Application - Hospital Pharmacies - Retail Pharma......
  • Global Skin Antiseptic Market Research Report 2022
    Published: 12-Aug-2022        Price: US 2900 Onwards        Pages: 96
    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type - Alcohol - Chlorhexidine and other diguanide - Quaternary ammonium compound - Halogenated phenol deri......
  • Global Hair Thickener Serum Market Research Report 2022
    Published: 12-Aug-2022        Price: US 2900 Onwards        Pages: 98
    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type - Organic - Conventional Segment by Application - Men - Women - Unisex ......
  • Global Patient Cleansing Products Market Research Report 2022
    Published: 12-Aug-2022        Price: US 2900 Onwards        Pages: 100
    Patient Cleansing Products market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Patient Cleansing Products market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028. Segment by Type - Hand & Body Care - Facial Care Segment by Applic......
  • Global Depression-MDD Drugs Market Research Report 2022
    Published: 12-Aug-2022        Price: US 2900 Onwards        Pages: 85
    Depression-MDD Drugs market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Depression-MDD Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028. Segment by Type - Selective Serotonin Reuptake Inhibitors, - Serotonin & Norepinephrine Reupt......
  • Global Long-Term Asthma Drugs Market Research Report 2022
    Published: 12-Aug-2022        Price: US 2900 Onwards        Pages: 85
    Long-Term Asthma Drugs market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Long-Term Asthma Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028. Segment by Type - Tablet - Spray Segment by Application - Hospital ......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs